- The US Food and Drug Administration is set to consider easing restrictions on over half a dozen unapproved peptide injections, which are popular among wellness influencers and celebrities.
- This review, scheduled for July, follows pledges from Health Secretary Robert F. Kennedy Jr., who has publicly supported peptides and used them himself, to loosen regulations.
- Many of these peptides, often marketed for muscle building, injury healing, or anti-ageing, lack significant research and have not been reviewed for safety by the FDA.
- Under President Joe Biden, the FDA previously restricted these substances, citing 'significant safety risks' and a lack of extensive human testing, a decision now being re-evaluated.
- The move has been influenced by pushback from the compounding industry and wellness entrepreneurs, who argue current restrictions foster an unregulated 'grey market' for imported chemicals.
IN FULL